MODIFICATION TO PROFILE -II

Enzyme Immunoassay, Phencyclidine

MEDTOX DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Medtox Diagnostics, Inc. with the FDA for Modification To Profile -ii.

Pre-market Notification Details

Device IDK002776
510k NumberK002776
Device Name:MODIFICATION TO PROFILE -II
ClassificationEnzyme Immunoassay, Phencyclidine
Applicant MEDTOX DIAGNOSTICS, INC. 1238 ANTHONY RD. Burlington,  NC  27215
ContactMichael Turanchik
CorrespondentMichael Turanchik
MEDTOX DIAGNOSTICS, INC. 1238 ANTHONY RD. Burlington,  NC  27215
Product CodeLCM  
Subsequent Product CodeDIO
Subsequent Product CodeDJG
Subsequent Product CodeDKE
Subsequent Product CodeDKZ
CFR Regulation Number510(k) Premarket Notification [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2000-09-06
Decision Date2000-09-28

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00690286000346 K002776 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.